Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.

Aubert P, Suárez-Fariñas M, Mitsui H, Johnson-Huang LM, Harden JL, Pierson KC, Dolan JG, Novitskaya I, Coats I, Estes J, Cowen EW, Plass N, Lee CC, Sun HW, Lowes MA, Goldbach-Mansky R.

PLoS One. 2012;7(11):e49408. doi: 10.1371/journal.pone.0049408. Epub 2012 Nov 30.

PMID:
23226210
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.

Goldbach-Mansky R.

Curr Rheumatol Rep. 2011 Apr;13(2):123-31. doi: 10.1007/s11926-011-0165-y. Review.

PMID:
21538043
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Cutaneous neutrophils infiltrates. Case 8. CINCA/NOMID syndrome].

Fraitag S.

Ann Pathol. 2011 Jun;31(3):203-7. doi: 10.1016/j.annpat.2011.05.005. Epub 2011 Jun 12. French. No abstract available.

PMID:
21737003
[PubMed - indexed for MEDLINE]
4.

"Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies.

Hedrich CM, Bruck N, Paul D, Hahn G, Gahr M, Rösen-Wolff A.

Rheumatol Int. 2012 Sep;32(9):2629-36. doi: 10.1007/s00296-011-2019-3. Epub 2011 Jul 22.

PMID:
21833523
[PubMed - indexed for MEDLINE]
5.

Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS).

Haverkamp MH, van de Vosse E, Goldbach-Mansky R, Holland SM.

Clin Exp Immunol. 2014 Sep;177(3):720-31. doi: 10.1111/cei.12361.

PMID:
24773462
[PubMed - indexed for MEDLINE]
6.

Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment.

Boschan C, Witt O, Lohse P, Foeldvari I, Zappel H, Schweigerer L.

Am J Med Genet A. 2006 Apr 15;140(8):883-6.

PMID:
16532456
[PubMed - indexed for MEDLINE]
7.

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.

Neven B, Marvillet I, Terrada C, Ferster A, Boddaert N, Couloignier V, Pinto G, Pagnier A, Bodemer C, Bodaghi B, Tardieu M, Prieur AM, Quartier P.

Arthritis Rheum. 2010 Jan;62(1):258-67. doi: 10.1002/art.25057.

PMID:
20039428
[PubMed - indexed for MEDLINE]
Free Article
8.

Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, Owens GK, Upchurch GR Jr, Ailawadi G.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):294-304. doi: 10.1161/ATVBAHA.112.300432. Epub 2013 Jan 3.

PMID:
23288154
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.

Sibley CH, Plass N, Snow J, Wiggs EA, Brewer CC, King KA, Zalewski C, Kim HJ, Bishop R, Hill S, Paul SM, Kicker P, Phillips Z, Dolan JG, Widemann B, Jayaprakash N, Pucino F, Stone DL, Chapelle D, Snyder C, Butman JA, Wesley R, Goldbach-Mansky R.

Arthritis Rheum. 2012 Jul;64(7):2375-86. doi: 10.1002/art.34409.

PMID:
22294344
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms.

Johnston WF, Salmon M, Pope NH, Meher A, Su G, Stone ML, Lu G, Owens GK, Upchurch GR Jr, Ailawadi G.

Circulation. 2014 Sep 9;130(11 Suppl 1):S51-9. doi: 10.1161/CIRCULATIONAHA.113.006800.

PMID:
25200056
[PubMed - indexed for MEDLINE]
11.

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, Rosenberg HF, Austin F, Remmers EF, Balow JE Jr, Rosenzweig S, Komarow H, Shoham NG, Wood G, Jones J, Mangra N, Carrero H, Adams BS, Moore TL, Schikler K, Hoffman H, Lovell DJ, Lipnick R, Barron K, O'Shea JJ, Kastner DL, Goldbach-Mansky R.

Arthritis Rheum. 2002 Dec;46(12):3340-8.

PMID:
12483741
[PubMed - indexed for MEDLINE]
Free Article
12.

Treating inflammation by blocking interleukin-1 in humans.

Dinarello CA, van der Meer JW.

Semin Immunol. 2013 Dec 15;25(6):469-84. doi: 10.1016/j.smim.2013.10.008. Epub 2013 Nov 23. Review.

PMID:
24275598
[PubMed - indexed for MEDLINE]
13.

CEACAM1 negatively regulates IL-1β production in LPS activated neutrophils by recruiting SHP-1 to a SYK-TLR4-CEACAM1 complex.

Lu R, Pan H, Shively JE.

PLoS Pathog. 2012;8(4):e1002597. doi: 10.1371/journal.ppat.1002597. Epub 2012 Apr 5.

PMID:
22496641
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.

Kuemmerle-Deschner JB, Lohse P, Koetter I, Dannecker GE, Reess F, Ummenhofer K, Koch S, Tzaribachev N, Bialkowski A, Benseler SM.

Arthritis Res Ther. 2011;13(6):R196. doi: 10.1186/ar3526. Epub 2011 Dec 6.

PMID:
22146561
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.

Brydges SD, Broderick L, McGeough MD, Pena CA, Mueller JL, Hoffman HM.

J Clin Invest. 2013 Nov 1;123(11):4695-705.

PMID:
24084736
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[CAPS treatment].

Jiménez Treviño S, Ramos Polo E.

Med Clin (Barc). 2011 Jan;136 Suppl 1:29-33. doi: 10.1016/S0025-7753(11)70006-9. Review. Spanish.

PMID:
21596184
[PubMed - indexed for MEDLINE]
17.

Interleukin-1β in innate inflammation, autophagy and immunity.

Joosten LA, Netea MG, Dinarello CA.

Semin Immunol. 2013 Dec 15;25(6):416-24. doi: 10.1016/j.smim.2013.10.018. Epub 2013 Nov 22.

PMID:
24275601
[PubMed - indexed for MEDLINE]
18.

Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement.

Kolivras A, Theunis A, Ferster A, Lipsker D, Sass U, Dussart A, André J.

J Cutan Pathol. 2011 Feb;38(2):202-8. doi: 10.1111/j.1600-0560.2010.01638.x. Epub 2010 Nov 10.

PMID:
21062341
[PubMed - indexed for MEDLINE]
19.

MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.

Wittkowski H, Kuemmerle-Deschner JB, Austermann J, Holzinger D, Goldbach-Mansky R, Gramlich K, Lohse P, Jung T, Roth J, Benseler SM, Foell D.

Ann Rheum Dis. 2011 Dec;70(12):2075-81. doi: 10.1136/ard.2011.152496. Epub 2011 Sep 8.

PMID:
21908452
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Anakinra for cryopyrin-associated periodic syndrome.

Koné-Paut I, Galeotti C.

Expert Rev Clin Immunol. 2014 Jan;10(1):7-18. doi: 10.1586/1744666X.2014.861325. Epub 2013 Nov 21. Review.

PMID:
24308832
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk